Free Trial

Arrowhead Pharmaceuticals (ARWR) Earnings Date, Estimates & Call Transcripts

Arrowhead Pharmaceuticals logo
$19.88 -0.35 (-1.73%)
Closing price 01/31/2025 04:00 PM Eastern
Extended Trading
$19.88 0.00 (0.00%)
As of 01/31/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Get Arrowhead Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Arrowhead Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ARWR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ARWR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Arrowhead Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20251-$1.07-$1.07-$1.07 
Q2 20253-$0.97$2.64$0.35 
Q3 20253-$0.99-$0.29-$0.60 
Q4 20254-$1.02$0.39-$0.53 
FY 202511($4.05)$1.67 ($1.85)

Arrowhead Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
2/10/2025
(Estimated)
-------
8/8/2024Q3 2024-$0.58-$1.38 -$0.80-$1.38$52.87M-
5/9/2024Q2 2024-$0.06-$1.02 -$0.96-$1.02$41.97M-
2/6/2024Q1 2024-$0.78-$1.24 -$0.46-$1.24$35.60M$3.55M
11/29/2023Q4 2023-$0.70-$1.03 -$0.33-$1.03$38.87M$16.10M
8/7/2023Q3 2023-$0.58-$0.96 -$0.38-$0.96$45.42M$15.83M
5/2/2023Q2 2023-$0.65$0.45+$1.10$0.45$45.48M$146.27M
2/6/2023Q4 2022$1.14-$0.39 -$1.53-$0.39$162.52M$62.55M

Arrowhead Pharmaceuticals Earnings - Frequently Asked Questions

Arrowhead Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, February 10th, 2025 based off last year's report dates. Learn more on ARWR's earnings history.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded annual revenue of $3.55 million.

Arrowhead Pharmaceuticals (NASDAQ:ARWR) has a recorded net income of -$599.49 million. ARWR has generated -$5.02 earnings per share over the last four quarters.

Arrowhead Pharmaceuticals's earnings are expected to grow from ($3.40) per share to ($3.18) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ARWR) was last updated on 2/1/2025 by MarketBeat.com Staff
From Our Partners